IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections.
Kimmig LM, Wu D, Gold M, Pettit NN, Pitrak D, Mueller J, Husain AN, Mutlu EA, Mutlu GM. IL-6 Inhibition in Critically Ill COVID-19 Patients Is Associated With Increased Secondary Infections. Front Med (Lausanne). 2020; 7:583897.